当前位置:首页 - 行情中心 - 九典制药(300705) - 财务分析

九典制药

(300705)

  

流通市值:75.55亿  总市值:125.01亿
流通股本:2.09亿   总股本:3.45亿

九典制药(300705)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.26亿元,每股收益0.36元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益210682.21万元,未分配利润101335.15万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产295827.72万元,负债85145.51万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入590,896,382.472,692,511,461.241,892,932,754.631,217,715,098.36
营业总成本472,495,995.842,314,990,942.391,548,770,713.931,014,593,754.99
营业利润147,291,041.83394,370,236.34355,386,467.64212,759,777.61
利润总额145,630,302.87402,160,983.67364,469,530.52222,358,358.35
净利润125,669,473.12368,260,790.68309,990,436.06197,628,193.99
其他综合收益000-
综合收益总额125,669,473.12368,260,790.68309,990,436.06197,628,193.99
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,483,571,928.41,429,958,213.61,686,691,228.111,214,162,005.76
非流动资产合计1,474,705,230.041,441,241,596.291,312,435,853.671,258,828,348.99
资产总计2,958,277,158.442,871,199,809.892,999,127,081.782,472,990,354.75
流动负债合计357,317,701.51415,561,579.96409,500,498.5396,683,985.69
非流动负债合计494,137,380.56482,368,330.39682,704,080.18375,870,208.71
负债合计851,455,082.07897,929,910.351,092,204,578.68772,554,194.4
归属于母公司股东权益合计2,106,822,076.371,973,269,899.541,906,922,503.11,700,436,160.35
股东权益合计2,106,822,076.371,973,269,899.541,906,922,503.11,700,436,160.35
负债和股东权益合计2,958,277,158.442,871,199,809.892,999,127,081.782,472,990,354.75
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计871,254,892.683,059,099,944.312,223,524,431.531,413,503,282.96
经营活动现金流出小计633,083,692.922,627,914,916.211,836,329,318.291,216,086,548.37
经营活动产生的现金流量净额238,171,199.76431,185,028.1387,195,113.24197,416,734.59
投资活动现金流入小计46,000182,242,701.5391,225,753.4291,165,753.42
投资活动现金流出小计126,418,884.93606,817,897.84372,557,706.63293,826,522.12
投资活动产生的现金流量净额-126,372,884.93-424,575,196.31-281,331,953.21-202,660,768.7
筹资活动现金流入小计9,000,000538,864,722468,864,72274,256,967
筹资活动现金流出小计11,949,833.82465,314,052.26140,635,520.5107,672,506.62
筹资活动产生的现金流量净额-2,949,833.8273,550,669.74328,229,201.5-33,415,539.62
汇率变动对现金及现金等价物的影响-000
现金及现金等价物净增加额108,848,481.0180,160,501.53434,092,361.53-38,659,573.73
期末现金及现金等价物余额524,059,257.13415,210,776.12769,142,636.12296,390,700.86
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华西证券崔文亮1.471.932.442024-04-25
平安证券叶寅,韩盟盟1.461.962.572024-04-24
浙商证券孙建,郭双喜1.051.371.802024-03-06
TOP↑